VMD — Viemed Healthcare Cashflow Statement
0.000.00%
- $264.37m
- $263.86m
- $183.01m
- 95
- 52
- 23
- 57
Annual cashflow statement for Viemed Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 8.53 | 31.5 | 9.13 | 6.22 | 10.2 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 13.7 | 12.9 | 11.7 | 14.3 | 6.77 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -10.3 | -10.2 | -13.6 | -10.1 | 7.78 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 19.1 | 35.1 | 22.5 | 27.7 | 45.2 |
Capital Expenditures | -13.4 | -13 | -19.7 | -22.9 | -26.1 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.574 | 4.63 | -0.003 | -1.08 | -26 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -12.8 | -8.41 | -19.7 | -24 | -52.1 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.33 | -9.07 | -5.32 | -15.3 | 2.83 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.94 | 17.6 | -2.57 | -11.5 | -4.08 |